Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736956 · ClinicalTrials.gov registry record · NA
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01736956 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 9 participants.
The verdict
NCT01736956, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
For fetuses with severe aortic stenosis, in utero balloon aortic valvuloplasty may improve fetal growth of left heart structures and thus improve potential for biventricular repair strategies after birth.
Interventions
- PROCEDURE Fetal Aortic Valvuloplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-10 |
| Est. Completion | 2022-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736956
The ClinicalTrials.gov registry entry for NCT01736956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fetal Aortic Valvuloplasty is the first listed.
NCT01736956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736956 about?
NCT01736956 is a clinical study titled "Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome". For fetuses with severe aortic stenosis, in utero balloon aortic valvuloplasty may improve fetal growth of left heart structures and thus improve potential for biventricular repair strategies after birth.
What is the current status of trial NCT01736956?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2012-10. Estimated completion is 2022-10.
What interventions are being tested in trial NCT01736956?
The interventions under investigation include: Fetal Aortic Valvuloplasty (PROCEDURE).
Who is sponsoring clinical trial NCT01736956?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.